Molecular Diagnostics Market - Forecast(2019 - 2024)

Report Code: HCR 0068 Report Format: PDF + Excel Database
Molecular Diagnostics Market: Making Personalized Medicine Possible

As per the National Center for Biotechnology Information, in the United States, misdiagnosis rate is approximately 10% to 15%, inflicting 100,000 deaths each year[1]. Bourgeoning occurrences of intricate diseases such as cancer, cardiovascular disease, neurological disease, and pulmonary embolism has been constantly challenging the omnipresent traditional diagnostic techniques. Owing to such inevitable scenario, the demand for advanced diagnostics are stroking the healthcare sector, and the molecular diagnostics market is all set to capitalize on this phenomenon. Molecular diagnostics is a diagnosis technique that utilizes DNA, RNA, and proteins to detect specific and intricate health condition or disease. Owing to its accuracy and effectiveness aiding medical diagnosis outputs, global molecular diagnostic market size hovered around $16.54 billion to $17.44billion as of 2018, and the demand will be progressing at a CAGR of 4.5%-4.8% during the forecast period 2019-2025.

Molecular Diagnostics Market Outlook:

Molecular diagnostics is a group of procedures applied to analyze biological markers at the molecular level such as genome and proteome in the individual's genetic code. The technique is employed by the flourishing healthcare sector to diagnose and monitor complex ailments, detect risk, and most importantly decide best personalized medicines and therapies for individual patients. Molecular diagnostics are beneficial in a wide array of medical fortes comprising of, infectious disease, oncology, human leucocyte antigen typing, coagulation, and pharmacogenomics.

Infectious diseases dominates the application segment. The sheer affluence can be validated by a WHO data that states lower respiratory infection-a kind of lung infectious disease, to be among the top 10 leading causes of mortality[2].  Lower respiratory infections was reckoned as the utmost lethal communicable disease, initiating 3.0 million deaths worldwide in 2016. Increase in the number of patients suffering from different viral and bacterial infections, such as HIV, Hepatitis C virus (HCV), Human Papillomavirus (HPV), and Chlamydia trachomatis is all set to stroke the molecular diagnostics market with abundant demand from infectious disease diagnosis segment. 

As per the American Cancer Society, in 2019, there will be probably 1,762,450 first-hand cancer cases diagnosed and 606,880 cancer related mortality in the United States[3].  Similarly, in American hospitals alone, the Centers for Disease Control (CDC) estimates that Healthcare-Acquired Infections (HAIs) account for an estimated 1.7 million infections and 99,000 associated deaths each year[4].  These two are among many other facts derived in this report to validate the regional outlook analysis of this report that states North America as the leading region in terms of molecular diagnostics market demand. This highly developed region with advanced medical infrastructure and huge influx on investments in R&D, withholds under its territory around 34% - 37% of the global molecular diagnostics marketplace. Molecular diagnostics are very significant in infectious disease analysis as they deliver effective and fast results. Therefore, the escalating popularity of infectious diseases and hospital-acquired infections are anticipated to determine the market growth.

Molecular Diagnostics Market Growth Drivers and Trends:

  • Upsurge in funding by federal bodies and private establishments for scientific studies in the molecular diagnosis sector is forecast to boost the market growth. Such encouraging developments are very effective in the course of new product development. For example, association of Accelerate Diagnostics with Jack W. Schuler Living Trust, the Schuler Family Foundation, Oracle Institutional Partners, L.P. and Oracle Partners for funding and rights offering for an aggregate purchase price of $19,499,608.80.
  • AdvanDx is a leading provider of rapid and accurate molecular diagnostic tests for identification of pathogens causing critical infections in hospitalized patients. AdvanDx raised a total of $49.7M in funding over 7 rounds. One of their funding was raised on Mar 17, 2015 from a Debt Financing round.
  • Increasing reliability for enhanced medical conduct by healthcare experts on various technological segments of molecular diagnostics such as polymerase chain reaction (PCR), hybridization, DNA sequencing, microarray, isothermal nucleic acid amplification technology (INAAT). Cumulative disposable income in developing regions is diverting traditional healthcare traffic towards intricate diagnostics augmenting molecular diagnostics.



Molecular Diagnostics Market Players Perspective:

Some of key players functional in the molecular diagnostics market profiled in the report are Roche, Hologic, QIAGEN, Abbott Laboratories, and Danaher Corporation.

In October 3, 2017, Abbot Laboratories closed the Alere acquisition. Abbott mentioned that with this transaction, its total diagnostics sales should be $7 billion. The corporation also forecast to arise as a lead player in the $7 billion point-of-care diagnostic space within the broader $50 billion in-vitro diagnostics market with this takeover.

Molecular Diagnostics Market Research Scope:

The base year of the study is 2018, with forecast done up to 2025. The study presents a thorough analysis of the competitive landscape, taking into account the market shares of the leading companies. It also provides information on unit shipments. These provide the key market participants with the necessary business intelligence and help them understand the future of the molecular diagnostics market. The assessment includes the forecast, an overview of the competitive structure, the market shares of the competitors, as well as the market trends, market demands, market drivers, market challenges, and product analysis. The market drivers and restraints have been assessed to fathom their impact over the forecast period. This report further identifies the key opportunities for growth while also detailing the key challenges and possible threats. The key areas of focus include the various technologies in molecular diagnostics market, and their specific applications in different types of ailments. 

Molecular Diagnostics Market Report: Industry Coverage

By Products: Analyzers, Reagents

End Users: Hospitals, Clinical Laboratories, Academics

By Applications: Oncology, Microbiology, Others

The molecular diagnostics market report also analyzes the major geographic regions for the market as well as the major countries for the market in these regions. The regions and countries covered in the study include:

  • North America: The U.S., Canada, Mexico
  • South America: Brazil, Venezuela, Argentina, Ecuador, Peru, Colombia, Costa Rica
  • Europe: The U.K., Germany, Italy, France, The Netherlands, Belgium, Spain, Denmark
  • APAC: China, Japan, Australia, South Korea, India, Taiwan, Malaysia, Hong Kong
  • Middle East and Africa: Israel, South Africa, Saudi Arabia 

Key Questions Addressed in the Molecular Diagnostics Market Report
1. Is the market for molecular diagnostics growing? How long will it continue to grow and at what rate? 
2. Which type of diagnostics presents the major growth opportunities? 
3. Is there a possibility for change in the market structure over time?  
4. Are additional developments needed for the existing product or services offerings or do the existing products meet the customer demands? 
5. Do the key vendors look for partnerships to expand their businesses with respect to geography or product? 
6. What are the short-term, long-term, and medium-term growth drivers for the market? 
7. What are the short-term, medium-term, and long-term challenges for the market? 
8. What are the short-term, medium-term, and long-term opportunities for the market 
9. Who are the top players/companies of the market? 
10. What are the recent innovations in the market? 
11. How many patents have been filed by the leading players? 
12. What are the types of patents filed by the leading players? 
13. What is our Vision 2030 for Molecular Diagnostics Market? 


A few focus points of this Research are given below:

  • Give a deep-dive analysis of the key operational strategies with focus on the corporate structure, R&D strategies, localization strategies, production capabilities, and sales performance of various companies
  • Provide an overview of the product portfolio, including product planning, development, and positioning
  • Discuss the role of technology companies in partnerships
  • Explore the regional sales activities
  • Analyze the market size and giving the forecast for current and future molecular diagnostics during the forecast 2018–2023
  • Analyze the competitive factors, competitors’ market shares, product capabilities, and supply chain structures 

Reference:

[1]https://www.ncbi.nlm.nih.gov/books/NBK499956/
[2]https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death
[3]https://www.cancer.org/research/cancer-facts-statistics/all-cancer-facts-figures/cancer-facts-figures-2019.html
[4]https://patientcarelink.org/improving-patient-care/healthcare-acquired-infections-hais/
1. Molecular Diagnostics Market - Overview
1.1. Definitions and Scope
2. Molecular Diagnostics Market - Executive summary
2.1. Market Revenue, Market Size and Key Trends by Company
2.2. Key Trends by type of Application
2.3. Key Trends segmented by Geography
3. Molecular Diagnostics Market 
3.1. Comparative analysis
3.1.1. Product Benchmarking - Top 10 companies
3.1.2. Top 5 Financials Analysis
3.1.3. Market Value split by Top 10 companies
3.1.4. Patent Analysis - Top 10 companies
3.1.5. Pricing Analysis 
4. Molecular Diagnostics Market – Startup companies Scenario Premium
4.1. Top 10 startup company Analysis by
4.1.1. Investment
4.1.2. Revenue
4.1.3. Market Shares
4.1.4. Market Size and Application Analysis
4.1.5. Venture Capital and Funding Scenario
5. Molecular Diagnostics Market – Industry Market Entry Scenario Premium
5.1. Regulatory Framework Overview
5.2. New Business and Ease of Doing business index
5.3. Case studies of successful ventures
5.4. Customer Analysis – Top 10 companies
6. Molecular Diagnostics Market Forces
6.1. Drivers
6.2. Constraints
6.3. Challenges
6.4. Porters five force model
6.4.1. Bargaining power of suppliers
6.4.2. Bargaining powers of customers
6.4.3. Threat of new entrants
6.4.4. Rivalry among existing players
6.4.5. Threat of substitutes 
7. Molecular Diagnostics Market -Strategic analysis
7.1. Value chain analysis
7.2. Opportunities analysis
7.3. Product life cycle
7.4. Suppliers and distributors Market Share
8. Molecular Diagnostics Market – By Products (Market Size -$Million / $Billion)
8.1. Market Size and Market Share Analysis 
8.2. Application Revenue and Trend Research
8.3. Product Segment Analysis
8.3.1. Analyzers
8.3.2. Reagents
9. Molecular Diagnostics Market – By Technology (Market Size -$Million / $Billion)
9.1. PCR
9.2. INAAT
9.3. Hybridization
9.4. DNA Sequencing and Next Generation Sequencing
9.5. Microarray
9.6. Spectral Karyotype Imaging (SKI)
9.7. Others
10. Molecular Diagnostics Market – By Applications (Market Size -$Million / $Billion)
10.1. Infectious Disease
10.1.1. HBV
10.1.2. HCV
10.1.3. HIV
10.1.4. TB
10.1.5. CT/NG
10.1.6. HPV
10.1.7. MRSA
10.1.8. Others
10.2. Oncology
10.2.1. Prostate Cancer
10.2.2. Breast Cancer
10.2.3. Colorectal Cancer
10.2.4. Others
10.3. Genetic Disease Screening
10.4. Blood Screening
10.5. Microbiology
10.6. Others
11. Molecular Diagnostics – By End Use Industry(Market Size -$Million / $Billion)
11.1. Segment type Size and Market Share Analysis 
11.2. Application Revenue and Trends by type of Application
11.3. Application Segment Analysis by Type
11.3.1. Hospitals
11.3.2. Clinical Laboratories
11.3.3. Academics
12. Molecular Diagnostics - By Geography (Market Size -$Million / $Billion)
12.1. Molecular Diagnostics Market - North America Segment Research
12.2. North America Market Research (Million / $Billion)
12.2.1. Segment type Size and Market Size Analysis 
12.2.2. Revenue and Trends
12.2.3. Application Revenue and Trends by type of Application
12.2.4. Company Revenue and Product Analysis
12.2.5. North America Product type and Application Market Size
12.2.5.1. U.S.
12.2.5.2. Canada 
12.2.5.3. Mexico 
12.2.5.4. Rest of North America
12.3. Molecular Diagnostics - South America Segment Research
12.4. South America Market Research (Market Size -$Million / $Billion)
12.4.1. Segment type Size and Market Size Analysis 
12.4.2. Revenue and Trends
12.4.3. Application Revenue and Trends by type of Application
12.4.4. Company Revenue and Product Analysis
12.4.5. South America Product type and Application Market Size
12.4.5.1. Brazil  
12.4.5.2. Venezuela
12.4.5.3. Argentina
12.4.5.4. Ecuador
12.4.5.5. Peru
12.4.5.6. Colombia 
12.4.5.7. Costa Rica
12.4.5.8. Rest of South America
12.5. Molecular Diagnostics - Europe Segment Research
12.6. Europe Market Research (Market Size -$Million / $Billion)
12.6.1. Segment type Size and Market Size Analysis 
12.6.2. Revenue and Trends
12.6.3. Application Revenue and Trends by type of Application
12.6.4. Company Revenue and Product Analysis
12.6.5. Europe Segment Product type and Application Market Size
12.6.5.1. U.K  
12.6.5.2. Germany 
12.6.5.3. Italy 
12.6.5.4. France
12.6.5.5. Netherlands
12.6.5.6. Belgium
12.6.5.7. Spain
12.6.5.8. Denmark
12.6.5.9. Rest of Europe
12.7. Molecular Diagnostics – APAC Segment Research
12.8. APAC Market Research (Market Size -$Million / $Billion)
12.8.1. Segment type Size and Market Size Analysis 
12.8.2. Revenue and Trends
12.8.3. Application Revenue and Trends by type of Application
12.8.4. Company Revenue and Product Analysis
12.8.5. APAC Segment – Product type and Application Market Size
12.8.5.1. China 
12.8.5.2. Australia
12.8.5.3. Japan 
12.8.5.4. South Korea
12.8.5.5. India
12.8.5.6. Taiwan
12.8.5.7. Malaysia
13. Molecular Diagnostics Market - Entropy
13.1. New product launches
13.2. M&A's, collaborations, JVs and partnerships
14. Molecular Diagnostics Market – Industry / Segment Competition landscape Premium
14.1. Market Share Analysis
14.1.1. Market Share by Country- Top companies
14.1.2. Market Share by Region- Top 10 companies
14.1.3. Market Share by type of Application – Top 10 companies
14.1.4. Market Share by type of Product / Product category- Top 10 companies
14.1.5. Market Share at global level- Top 10 companies
14.1.6. Best Practises for companies
15. Molecular Diagnostics Market – Key Company List by Country Premium
16. Molecular Diagnostics Market Company Analysis
16.1. Market Share, Company Revenue, Products, M&A, Developments
16.2. Abbott Diagnostics, Inc.
16.3. Beckman Coulter, Inc.
16.4. Becton, Dickinson & Co
16.5. Biomérieux
16.6. Cepheid, Inc.
16.7. Gen-Probe, Inc. (Hologic, Inc.)
16.8. Novartis AG
16.9. Qiagen N.V.
16.10. F. Hoffmann-La Roche Ltd
16.11. Siemens Healthcare 
16.12. Company 11
16.13. Company 12
16.14. Company 13 and more
"*Financials would be provided on a best efforts basis for private companies"
17. Molecular Diagnostics Market -Appendix
17.1. Abbreviations
17.2. Sources
18. Molecular Diagnostics Market -Methodology Premium
18.1. Research Methodology
18.1.1. Company Expert Interviews
18.1.2. Industry Databases
18.1.3. Associations
18.1.4. Company News
18.1.5. Company Annual Reports
18.1.6. Application Trends
18.1.7. New Products and Product database
18.1.8. Company Transcripts
18.1.9. R&D Trends
18.1.10. Key Opinion Leaders Interviews
18.1.11. Supply and Demand Trends
List of Tables

Table 1: Molecular Diagnostics Market Overview 2019-2024
Table 2: Molecular Diagnostics Market Leader Analysis 2018-2019 (US$)
Table 3: Molecular Diagnostics Market Product Analysis 2018-2019 (US$)
Table 4: Molecular Diagnostics Market End User Analysis 2018-2019 (US$)
Table 5: Molecular Diagnostics Market Patent Analysis 2013-2018* (US$)
Table 6: Molecular Diagnostics Market Financial Analysis 2018-2019 (US$)
Table 7: Molecular Diagnostics Market Driver Analysis 2018-2019 (US$)
Table 8: Molecular Diagnostics Market Challenges Analysis 2018-2019 (US$)
Table 9: Molecular Diagnostics Market Constraint Analysis 2018-2019 (US$)
Table 10: Molecular Diagnostics Market Supplier Bargaining Power Analysis 2018-2019 (US$)
Table 11: Molecular Diagnostics Market Buyer Bargaining Power Analysis 2018-2019 (US$)
Table 12: Molecular Diagnostics Market Threat of Substitutes Analysis 2018-2019 (US$)
Table 13: Molecular Diagnostics Market Threat of New Entrants Analysis 2018-2019 (US$)
Table 14: Molecular Diagnostics Market Degree of Competition Analysis 2018-2019 (US$)
Table 15: Molecular Diagnostics Market Value Chain Analysis 2018-2019 (US$)
Table 16: Molecular Diagnostics Market Pricing Analysis 2019-2024 (US$)
Table 17: Molecular Diagnostics Market Opportunities Analysis 2019-2024 (US$)
Table 18: Molecular Diagnostics Market Product Life Cycle Analysis 2019-2024 (US$)
Table 19: Molecular Diagnostics Market Supplier Analysis 2018-2019 (US$)
Table 20: Molecular Diagnostics Market Distributor Analysis 2018-2019 (US$)
Table 21: Molecular Diagnostics Market Trend Analysis 2018-2019 (US$)
Table 22: Molecular Diagnostics Market Size 2018 (US$)
Table 23: Molecular Diagnostics Market Forecast Analysis 2019-2024 (US$)
Table 24: Molecular Diagnostics Market Sales Forecast Analysis 2019-2024 (Units)
Table 25: Molecular Diagnostics Market, Revenue & Volume, By Products, 2019-2024 ($)
Table 26: Molecular Diagnostics Market By Products, Revenue & Volume, By Analyzers, 2019-2024 ($)
Table 27: Molecular Diagnostics Market By Products, Revenue & Volume, By Reagents, 2019-2024 ($)
Table 28: Molecular Diagnostics Market, Revenue & Volume, By Technology, 2019-2024 ($)
Table 29: Molecular Diagnostics Market By Technology, Revenue & Volume, By PCR, 2019-2024 ($)
Table 30: Molecular Diagnostics Market By Technology, Revenue & Volume, By INAAT, 2019-2024 ($)
Table 31: Molecular Diagnostics Market By Technology, Revenue & Volume, By Hybridization, 2019-2024 ($)
Table 32: Molecular Diagnostics Market By Technology, Revenue & Volume, By DNA Sequencing and Next Generation Sequencing, 2019-2024 ($)
Table 33: Molecular Diagnostics Market By Technology, Revenue & Volume, By Spectral Karyotype Imaging, 2019-2024 ($)
Table 34: Molecular Diagnostics Market, Revenue & Volume, By Applications, 2019-2024 ($)
Table 35: Molecular Diagnostics Market By Applications, Revenue & Volume, By Infectious Disease, 2019-2024 ($)
Table 36: Molecular Diagnostics Market By Applications, Revenue & Volume, By Oncology, 2019-2024 ($)
Table 37: Molecular Diagnostics Market By Applications, Revenue & Volume, By Genetic Disease Screening, 2019-2024 ($)
Table 38: Molecular Diagnostics Market By Applications, Revenue & Volume, By Blood Screening, 2019-2024 ($)
Table 39: Molecular Diagnostics Market By Applications, Revenue & Volume, By Microbiology, 2019-2024 ($)
Table 40: Molecular Diagnostics Market, Revenue & Volume, By End Users, 2019-2024 ($)
Table 41: Molecular Diagnostics Market By End Users, Revenue & Volume, By Hospitals, 2019-2024 ($)
Table 42: Molecular Diagnostics Market By End Users, Revenue & Volume, By Clinical Laboratories, 2019-2024 ($)
Table 43: Molecular Diagnostics Market By End Users, Revenue & Volume, By Academics, 2019-2024 ($)
Table 44: North America Molecular Diagnostics Market, Revenue & Volume, By Products, 2019-2024 ($)
Table 45: North America Molecular Diagnostics Market, Revenue & Volume, By Technology, 2019-2024 ($)
Table 46: North America Molecular Diagnostics Market, Revenue & Volume, By Applications, 2019-2024 ($)
Table 47: North America Molecular Diagnostics Market, Revenue & Volume, By End Users, 2019-2024 ($)
Table 48: South america Molecular Diagnostics Market, Revenue & Volume, By Products, 2019-2024 ($)
Table 49: South america Molecular Diagnostics Market, Revenue & Volume, By Technology, 2019-2024 ($)
Table 50: South america Molecular Diagnostics Market, Revenue & Volume, By Applications, 2019-2024 ($)
Table 51: South america Molecular Diagnostics Market, Revenue & Volume, By End Users, 2019-2024 ($)
Table 52: Europe Molecular Diagnostics Market, Revenue & Volume, By Products, 2019-2024 ($)
Table 53: Europe Molecular Diagnostics Market, Revenue & Volume, By Technology, 2019-2024 ($)
Table 54: Europe Molecular Diagnostics Market, Revenue & Volume, By Applications, 2019-2024 ($)
Table 55: Europe Molecular Diagnostics Market, Revenue & Volume, By End Users, 2019-2024 ($)
Table 56: APAC Molecular Diagnostics Market, Revenue & Volume, By Products, 2019-2024 ($)
Table 57: APAC Molecular Diagnostics Market, Revenue & Volume, By Technology, 2019-2024 ($)
Table 58: APAC Molecular Diagnostics Market, Revenue & Volume, By Applications, 2019-2024 ($)
Table 59: APAC Molecular Diagnostics Market, Revenue & Volume, By End Users, 2019-2024 ($)
Table 60: Middle East & Africa Molecular Diagnostics Market, Revenue & Volume, By Products, 2019-2024 ($)
Table 61: Middle East & Africa Molecular Diagnostics Market, Revenue & Volume, By Technology, 2019-2024 ($)
Table 62: Middle East & Africa Molecular Diagnostics Market, Revenue & Volume, By Applications, 2019-2024 ($)
Table 63: Middle East & Africa Molecular Diagnostics Market, Revenue & Volume, By End Users, 2019-2024 ($)
Table 64: Russia Molecular Diagnostics Market, Revenue & Volume, By Products, 2019-2024 ($)
Table 65: Russia Molecular Diagnostics Market, Revenue & Volume, By Technology, 2019-2024 ($)
Table 66: Russia Molecular Diagnostics Market, Revenue & Volume, By Applications, 2019-2024 ($)
Table 67: Russia Molecular Diagnostics Market, Revenue & Volume, By End Users, 2019-2024 ($)
Table 68: Israel Molecular Diagnostics Market, Revenue & Volume, By Products, 2019-2024 ($)
Table 69: Israel Molecular Diagnostics Market, Revenue & Volume, By Technology, 2019-2024 ($)
Table 70: Israel Molecular Diagnostics Market, Revenue & Volume, By Applications, 2019-2024 ($)
Table 71: Israel Molecular Diagnostics Market, Revenue & Volume, By End Users, 2019-2024 ($)
Table 72: Top Companies 2018 (US$)Molecular Diagnostics Market, Revenue & Volume
Table 73: Product Launch 2018-2019Molecular Diagnostics Market, Revenue & Volume
Table 74: Mergers & Acquistions 2018-2019Molecular Diagnostics Market, Revenue & Volume


List of Figures

Figure 1: Overview of Molecular Diagnostics Market 2019-2024
Figure 2: Market Share Analysis for Molecular Diagnostics Market 2018 (US$)
Figure 3: Product Comparison in Molecular Diagnostics Market 2018-2019 (US$)
Figure 4: End User Profile for Molecular Diagnostics Market 2018-2019 (US$)
Figure 5: Patent Application and Grant in Molecular Diagnostics Market 2013-2018* (US$)
Figure 6: Top 5 Companies Financial Analysis in Molecular Diagnostics Market 2018-2019 (US$)
Figure 7: Market Entry Strategy in Molecular Diagnostics Market 2018-2019
Figure 8: Ecosystem Analysis in Molecular Diagnostics Market 2018
Figure 9: Average Selling Price in Molecular Diagnostics Market 2019-2024
Figure 10: Top Opportunites in Molecular Diagnostics Market 2018-2019
Figure 11: Market Life Cycle Analysis in Molecular Diagnostics Market
Figure 12: GlobalBy ProductsMolecular Diagnostics Market Revenue, 2019-2024 ($)
Figure 13: GlobalBy TechnologyMolecular Diagnostics Market Revenue, 2019-2024 ($)
Figure 14: GlobalBy ApplicationsMolecular Diagnostics Market Revenue, 2019-2024 ($)
Figure 15: GlobalBy End UsersMolecular Diagnostics Market Revenue, 2019-2024 ($)
Figure 16: Global Molecular Diagnostics Market - By Geography
Figure 17: Global Molecular Diagnostics Market Value & Volume, By Geography, 2019-2024 ($) 
Figure 18: Global Molecular Diagnostics Market CAGR, By Geography, 2019-2024 (%)
Figure 19: North America Molecular Diagnostics Market Value & Volume, 2019-2024 ($)
Figure 20: US Molecular Diagnostics Market Value & Volume, 2019-2024 ($)
Figure 21: US GDP and Population, 2018-2019 ($)
Figure 22: US GDP – Composition of 2018, By Sector of Origin
Figure 23: US Export and Import Value & Volume, 2018-2019 ($)
Figure 24: Canada Molecular Diagnostics Market Value & Volume, 2019-2024 ($)
Figure 25: Canada GDP and Population, 2018-2019 ($)
Figure 26: Canada GDP – Composition of 2018, By Sector of Origin
Figure 27: Canada Export and Import Value & Volume, 2018-2019 ($)
Figure 28: Mexico Molecular Diagnostics Market Value & Volume, 2019-2024 ($)
Figure 29: Mexico GDP and Population, 2018-2019 ($)
Figure 30: Mexico GDP – Composition of 2018, By Sector of Origin
Figure 31: Mexico Export and Import Value & Volume, 2018-2019 ($)
Figure 32: South America Molecular Diagnostics Market Value & Volume, 2019-2024 ($)
Figure 33: Brazil Molecular Diagnostics Market Value & Volume, 2019-2024 ($)
Figure 34: Brazil GDP and Population, 2018-2019 ($)
Figure 35: Brazil GDP – Composition of 2018, By Sector of Origin
Figure 36: Brazil Export and Import Value & Volume, 2018-2019 ($)
Figure 37: Venezuela Molecular Diagnostics Market Value & Volume, 2019-2024 ($)
Figure 38: Venezuela GDP and Population, 2018-2019 ($)
Figure 39: Venezuela GDP – Composition of 2018, By Sector of Origin
Figure 40: Venezuela Export and Import Value & Volume, 2018-2019 ($)
Figure 41: Argentina Molecular Diagnostics Market Value & Volume, 2019-2024 ($)
Figure 42: Argentina GDP and Population, 2018-2019 ($)
Figure 43: Argentina GDP – Composition of 2018, By Sector of Origin
Figure 44: Argentina Export and Import Value & Volume, 2018-2019 ($)
Figure 45: Ecuador Molecular Diagnostics Market Value & Volume, 2019-2024 ($)
Figure 46: Ecuador GDP and Population, 2018-2019 ($)
Figure 47: Ecuador GDP – Composition of 2018, By Sector of Origin
Figure 48: Ecuador Export and Import Value & Volume, 2018-2019 ($)
Figure 49: Peru Molecular Diagnostics Market Value & Volume, 2019-2024 ($)
Figure 50: Peru GDP and Population, 2018-2019 ($)
Figure 51: Peru GDP – Composition of 2018, By Sector of Origin
Figure 52: Peru Export and Import Value & Volume, 2018-2019 ($)
Figure 53: Colombia Molecular Diagnostics Market Value & Volume, 2019-2024 ($)
Figure 54: Colombia GDP and Population, 2018-2019 ($)
Figure 55: Colombia GDP – Composition of 2018, By Sector of Origin
Figure 56: Colombia Export and Import Value & Volume, 2018-2019 ($)
Figure 57: Costa Rica Molecular Diagnostics Market Value & Volume, 2019-2024 ($)
Figure 58: Costa Rica GDP and Population, 2018-2019 ($)
Figure 59: Costa Rica GDP – Composition of 2018, By Sector of Origin
Figure 60: Costa Rica Export and Import Value & Volume, 2018-2019 ($)
Figure 61: Europe Molecular Diagnostics Market Value & Volume, 2019-2024 ($)
Figure 62: U.K Molecular Diagnostics Market Value & Volume, 2019-2024 ($)
Figure 63: U.K GDP and Population, 2018-2019 ($)
Figure 64: U.K GDP – Composition of 2018, By Sector of Origin
Figure 65: U.K Export and Import Value & Volume, 2018-2019 ($)
Figure 66: Germany Molecular Diagnostics Market Value & Volume, 2019-2024 ($)
Figure 67: Germany GDP and Population, 2018-2019 ($)
Figure 68: Germany GDP – Composition of 2018, By Sector of Origin
Figure 69: Germany Export and Import Value & Volume, 2018-2019 ($)
Figure 70: Italy Molecular Diagnostics Market Value & Volume, 2019-2024 ($)
Figure 71: Italy GDP and Population, 2018-2019 ($)
Figure 72: Italy GDP – Composition of 2018, By Sector of Origin
Figure 73: Italy Export and Import Value & Volume, 2018-2019 ($)
Figure 74: France Molecular Diagnostics Market Value & Volume, 2019-2024 ($)
Figure 75: France GDP and Population, 2018-2019 ($)
Figure 76: France GDP – Composition of 2018, By Sector of Origin
Figure 77: France Export and Import Value & Volume, 2018-2019 ($)
Figure 78: Netherlands Molecular Diagnostics Market Value & Volume, 2019-2024 ($)
Figure 79: Netherlands GDP and Population, 2018-2019 ($)
Figure 80: Netherlands GDP – Composition of 2018, By Sector of Origin
Figure 81: Netherlands Export and Import Value & Volume, 2018-2019 ($)
Figure 82: Belgium Molecular Diagnostics Market Value & Volume, 2019-2024 ($)
Figure 83: Belgium GDP and Population, 2018-2019 ($)
Figure 84: Belgium GDP – Composition of 2018, By Sector of Origin
Figure 85: Belgium Export and Import Value & Volume, 2018-2019 ($)
Figure 86: Spain Molecular Diagnostics Market Value & Volume, 2019-2024 ($)
Figure 87: Spain GDP and Population, 2018-2019 ($)
Figure 88: Spain GDP – Composition of 2018, By Sector of Origin
Figure 89: Spain Export and Import Value & Volume, 2018-2019 ($)
Figure 90: Denmark Molecular Diagnostics Market Value & Volume, 2019-2024 ($)
Figure 91: Denmark GDP and Population, 2018-2019 ($)
Figure 92: Denmark GDP – Composition of 2018, By Sector of Origin
Figure 93: Denmark Export and Import Value & Volume, 2018-2019 ($)
Figure 94: APAC Molecular Diagnostics Market Value & Volume, 2019-2024 ($)
Figure 95: China Molecular Diagnostics Market Value & Volume, 2019-2024
Figure 96: China GDP and Population, 2018-2019 ($)
Figure 97: China GDP – Composition of 2018, By Sector of Origin
Figure 98: China Export and Import Value & Volume, 2018-2019 ($)Molecular Diagnostics Market China Export and Import Value & Volume, 2018-2019 ($)
Figure 99: Australia Molecular Diagnostics Market Value & Volume, 2019-2024 ($)
Figure 100: Australia GDP and Population, 2018-2019 ($)
Figure 101: Australia GDP – Composition of 2018, By Sector of Origin
Figure 102: Australia Export and Import Value & Volume, 2018-2019 ($)
Figure 103: South Korea Molecular Diagnostics Market Value & Volume, 2019-2024 ($)
Figure 104: South Korea GDP and Population, 2018-2019 ($)
Figure 105: South Korea GDP – Composition of 2018, By Sector of Origin
Figure 106: South Korea Export and Import Value & Volume, 2018-2019 ($)
Figure 107: India Molecular Diagnostics Market Value & Volume, 2019-2024 ($)
Figure 108: India GDP and Population, 2018-2019 ($)
Figure 109: India GDP – Composition of 2018, By Sector of Origin
Figure 110: India Export and Import Value & Volume, 2018-2019 ($)
Figure 111: Taiwan Molecular Diagnostics Market Value & Volume, 2019-2024 ($)
Figure 112: Taiwan GDP and Population, 2018-2019 ($)
Figure 113: Taiwan GDP – Composition of 2018, By Sector of Origin
Figure 114: Taiwan Export and Import Value & Volume, 2018-2019 ($)
Figure 115: Malaysia Molecular Diagnostics Market Value & Volume, 2019-2024 ($)
Figure 116: Malaysia GDP and Population, 2018-2019 ($)
Figure 117: Malaysia GDP – Composition of 2018, By Sector of Origin
Figure 118: Malaysia Export and Import Value & Volume, 2018-2019 ($)
Figure 119: Hong Kong Molecular Diagnostics Market Value & Volume, 2019-2024 ($)
Figure 120: Hong Kong GDP and Population, 2018-2019 ($)
Figure 121: Hong Kong GDP – Composition of 2018, By Sector of Origin
Figure 122: Hong Kong Export and Import Value & Volume, 2018-2019 ($)
Figure 123: Middle East & Africa Molecular Diagnostics Market Middle East & Africa 3D Printing Market Value & Volume, 2019-2024 ($)
Figure 124: Russia Molecular Diagnostics Market Value & Volume, 2019-2024 ($)
Figure 125: Russia GDP and Population, 2018-2019 ($)
Figure 126: Russia GDP – Composition of 2018, By Sector of Origin
Figure 127: Russia Export and Import Value & Volume, 2018-2019 ($)
Figure 128: Israel Molecular Diagnostics Market Value & Volume, 2019-2024 ($)
Figure 129: Israel GDP and Population, 2018-2019 ($)
Figure 130: Israel GDP – Composition of 2018, By Sector of Origin
Figure 131: Israel Export and Import Value & Volume, 2018-2019 ($)
Figure 132: Entropy Share, By Strategies, 2018-2019* (%)Molecular Diagnostics Market
Figure 133: Developments, 2018-2019*Molecular Diagnostics Market
Figure 134: Company 1 Molecular Diagnostics Market Net Revenue, By Years, 2018-2019* ($)
Figure 135: Company 1 Molecular Diagnostics Market Net Revenue Share, By Business segments, 2018 (%)
Figure 136: Company 1 Molecular Diagnostics Market Net Sales Share, By Geography, 2018 (%)
Figure 137: Company 2 Molecular Diagnostics Market Net Revenue, By Years, 2018-2019* ($)
Figure 138: Company 2 Molecular Diagnostics Market Net Revenue Share, By Business segments, 2018 (%)
Figure 139: Company 2 Molecular Diagnostics Market Net Sales Share, By Geography, 2018 (%)
Figure 140: Company 3 Molecular Diagnostics Market Net Revenue, By Years, 2018-2019* ($)
Figure 141: Company 3 Molecular Diagnostics Market Net Revenue Share, By Business segments, 2018 (%)
Figure 142: Company 3 Molecular Diagnostics Market Net Sales Share, By Geography, 2018 (%)
Figure 143: Company 4 Molecular Diagnostics Market Net Revenue, By Years, 2018-2019* ($)
Figure 144: Company 4 Molecular Diagnostics Market Net Revenue Share, By Business segments, 2018 (%)
Figure 145: Company 4 Molecular Diagnostics Market Net Sales Share, By Geography, 2018 (%)
Figure 146: Company 5 Molecular Diagnostics Market Net Revenue, By Years, 2018-2019* ($)
Figure 147: Company 5 Molecular Diagnostics Market Net Revenue Share, By Business segments, 2018 (%)
Figure 148: Company 5 Molecular Diagnostics Market Net Sales Share, By Geography, 2018 (%)
Figure 149: Company 6 Molecular Diagnostics Market Net Revenue, By Years, 2018-2019* ($)
Figure 150: Company 6 Molecular Diagnostics Market Net Revenue Share, By Business segments, 2018 (%)
Figure 151: Company 6 Molecular Diagnostics Market Net Sales Share, By Geography, 2018 (%)
Figure 152: Company 7 Molecular Diagnostics Market Net Revenue, By Years, 2018-2019* ($)
Figure 153: Company 7 Molecular Diagnostics Market Net Revenue Share, By Business segments, 2018 (%)
Figure 154: Company 7 Molecular Diagnostics Market Net Sales Share, By Geography, 2018 (%)
Figure 155: Company 8 Molecular Diagnostics Market Net Revenue, By Years, 2018-2019* ($)
Figure 156: Company 8 Molecular Diagnostics Market Net Revenue Share, By Business segments, 2018 (%)
Figure 157: Company 8 Molecular Diagnostics Market Net Sales Share, By Geography, 2018 (%)
Figure 158: Company 9 Molecular Diagnostics Market Net Revenue, By Years, 2018-2019* ($)
Figure 159: Company 9 Molecular Diagnostics Market Net Revenue Share, By Business segments, 2018 (%)
Figure 160: Company 9 Molecular Diagnostics Market Net Sales Share, By Geography, 2018 (%)
Figure 161: Company 10 Molecular Diagnostics Market Net Revenue, By Years, 2018-2019* ($)
Figure 162: Company 10 Molecular Diagnostics Market Net Revenue Share, By Business segments, 2018 (%)
Figure 163: Company 10 Molecular Diagnostics Market Net Sales Share, By Geography, 2018 (%)
Figure 164: Company 11 Molecular Diagnostics Market Net Revenue, By Years, 2018-2019* ($)
Figure 165: Company 11 Molecular Diagnostics Market Net Revenue Share, By Business segments, 2018 (%)
Figure 166: Company 11 Molecular Diagnostics Market Net Sales Share, By Geography, 2018 (%)
Figure 167: Company 12 Molecular Diagnostics Market Net Revenue, By Years, 2018-2019* ($)
Figure 168: Company 12 Molecular Diagnostics Market Net Revenue Share, By Business segments, 2018 (%)
Figure 169: Company 12 Molecular Diagnostics Market Net Sales Share, By Geography, 2018 (%)
Figure 170: Company 13 Molecular Diagnostics Market Net Revenue, By Years, 2018-2019* ($)
Figure 171: Company 13 Molecular Diagnostics Market Net Revenue Share, By Business segments, 2018 (%)
Figure 172: Company 13 Molecular Diagnostics Market Net Sales Share, By Geography, 2018 (%)
Figure 173: Company 14 Molecular Diagnostics Market Net Revenue, By Years, 2018-2019* ($)
Figure 174: Company 14 Molecular Diagnostics Market Net Revenue Share, By Business segments, 2018 (%)
Figure 175: Company 14 Molecular Diagnostics Market Net Sales Share, By Geography, 2018 (%)
Figure 176: Company 15 Molecular Diagnostics Market Net Revenue, By Years, 2018-2019* ($)
Figure 177: Company 15 Molecular Diagnostics Market Net Revenue Share, By Business segments, 2018 (%)
Figure 178: Company 15 Molecular Diagnostics Market Net Sales Share, By Geography, 2018 (%)